Microbial molecule that disarms inflammation discovered, offering new diabetes treatment strategy

An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a microbial metabolite called trimethylamine (TMA). Published in Nature Metabolism, the study reveals that TMA, produced by gut bacteria from dietary choline, can block a key immune pathway and improve blood sugar control.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup